Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $1.55B
Liabilities Breakdown FY2022
Total Liabilities: $1.19B
Asset Breakdown
Total Assets: $1.55B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $132.9M | 8.6% |
| Accounts Receivable | $40.4M | 2.6% |
| Inventory | $26.8M | 1.7% |
| Property, Plant & Equipment | $259.7M | 16.8% |
| Goodwill | $44.4M | 2.9% |
| Intangible Assets | $160.1M | 10.4% |
| Other Assets | $881.1M | 57.0% |
Liabilities Breakdown
Total Liabilities: $1.19B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $43.3M | 3.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.15B | 96.4% |